Acne treatments and processed foods

JPWO2024062966A5Inactive Publication Date: 2024-11-08
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024501707
Authority / Receiving Office
JP · JP
Patent Type
Applications
Filing Date
2024-10-22
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 2024062966000001
    Figure 2024062966000001
  • Figure 2024062966000002
    Figure 2024062966000002
  • Figure 2024062966000003
    Figure 2024062966000003
Patent Text Reader

Abstract

The present invention provides an anti-inflammatory agent containing a compound having an anti-inflammatory effect and contained in juvenile citrullus. The anti-inflammatory agent comprises a compound represented by formula (1) or formula (2) as an active ingredient.
Need to check novelty before this filing date? Find Prior Art

Description

An anti-inflammatory agent containing a watermelon-derived compound as an active ingredient

[0001] The present invention relates to an anti-inflammatory agent containing a compound derived from watermelon as an active ingredient.

[0002] Plants germinate from seeds and produce various substances as they grow. Some substances are only produced at certain stages of growth and are not produced after that stage.

[0003] Watermelon is rich in citrulline, an amino acid, in addition to lycopene and arginine, and is known to have beneficial effects on improving diabetes and inflammation. Furthermore, Patent Document 1 introduces a new substance obtained from young watermelon fruit. This substance is said to have beneficial effects on beauty, such as reducing swelling through its diuretic effect and providing antioxidant effects. Young watermelon fruit, in particular, can be eaten by humans and is a substance safe for the human body.

[0004] Japanese Patent Application Laid-Open No. 2020-203885

[0005] As described above, substances that have antioxidant properties and are guaranteed to be safe are expected to be effective in treating various diseases and maintaining health from the viewpoint of protecting the body. The inventors have confirmed that the compound disclosed in Patent Document 1 also has an anti-inflammatory effect, which led to the invention of the present invention.

[0006] The present invention was conceived based on the finding that substances contained in young watermelon fruits have anti-inflammatory effects.

[0007] More specifically, the anti-inflammatory agent according to the present invention contains as an active ingredient a compound derived from watermelon and represented by formula (1) or (2).

[0008]

[0009]

[0010] The compounds of formulas (1) and (2) are substances extracted from young watermelon fruits, are highly safe, and have anti-inflammatory properties. As shown in the following examples, these compounds suppress inflammation by weakening the NK-κB signaling pathway, which causes inflammation. Therefore, they are less likely to cause side effects and can effectively suppress or treat inflammatory diseases such as acne. The compounds of formulas (1) and (2) can also be used as cosmetics.

[0011] 1 is a solvent distribution flow diagram for the watermelon young fruit extract according to the present invention. 2 is a graph showing the antibacterial activity of CH and CT (abbreviations for the compounds of the present invention: the same applies hereinafter) against Propionibacterium acnes. 3 is a graph showing the NO production inhibitory effect of CH and CT in LPS / IFN-γ-stimulated cells. 4 is a graph showing the NO production inhibitory effect of CH and CT in cells stimulated with heat-killed Propionibacterium acnes cells. 5 shows the results of examining the protein levels of iNOS and COX-2, which are NO production signals, in cells stimulated with heat-killed Propionibacterium acnes cells. (a) Western blotting results. (b) iNOS results. (c) COX-2 results. 6 is a graph showing the mRNA levels of NO production signal proteins in cells stimulated with heat-killed Propionibacterium acnes cells. (a) iNOS results. (b) COX-2 results. 7 is a graph showing the mRNA levels of inflammatory cytokines (TNF-α, IL-6) in cells stimulated with heat-killed Propionibacterium acnes cells. (a) TNF-α results. (b) Results for IL-6. Results of examining protein expression of the heme-degrading enzyme HO-1 following CH and CT treatment. (a) Results of examining the mRNA level of HO-1. (b) Results of Western blotting. (c) Results of examining the protein level of HO-1. Results of examining mRNA expression in M1 / M2 macrophages following CH and CT treatment. (a) Results for CD80. (b) Results for CD86. Graphs examining the effect on NF-κB transcription activity in cells stimulated with heat-killed Propionibacterium acnes cells.

[0012] The compound according to the present invention and the pharmaceutical composition, processed food composition, and anti-skin aging composition containing the compound as an active ingredient will be described below with reference to examples. Note that the following description exemplifies one embodiment of the present invention and one example, and the present invention is not limited to the following description. The following description can be modified within the scope of the present invention.

[0013] The anti-inflammatory agent according to the present invention is characterized by containing a compound represented by formula (1) or (2) as an active ingredient.

[0014]

[0015]

[0016] The compound of formula (1) is 2-caffeoyl-3-hydroxy-3-methylbutyric 4'-β-D-glucopyranosyloxy-3'-hydroxybenzyl ester, abbreviated as 4G3HBE and also known as "Citrulluside H." Hereinafter referred to as CH.

[0017] The compound of formula (2) is 2-caffeoyl-3-hydroxy-3-methylbutyric 4'-β-D-glucopyranosyloxybenzyl ester, abbreviated as 4GBE and also known as "Citrulluside T." Hereinafter, this compound will be referred to as CT.

[0018] CH and CT are obtained from young watermelon fruits. Watermelon (scientific name: Citrullus lanatus) is the fruit of an annual climbing plant in the Cucurbitaceae family. Young fruits refer to fruits that take 10 to 20 days to ripen after fruiting. There are no particular limitations on the type, and varieties that can be suitably used include large red-fleshed varieties, seedless red-fleshed varieties, black-skinned varieties, elongated varieties, yellow-fleshed varieties, and orange-colored varieties.

[0019] Figure 1 shows a solvent partitioning flow diagram for watermelon seed extract. The extraction method involves washing and crushing the seed watermelon, then immersing the crushed material in ethanol to obtain an ethanol extract. The ethanol extract was partitioned into hexane (Hexane Fr.), ethyl acetate (EtOAc Fr.), butanol (n-BuOH Fr.), and distilled water (Water Fr.) to prepare fractions. The ethyl acetate extract was then isolated by column fractionation to obtain the two compounds listed above.

[0020] The anti-inflammatory agent of the present invention was conceived upon the discovery that CH and CT have anti-inflammatory effects. Therefore, the anti-inflammatory agent of the present invention contains at least one of CH and CT. These compounds may be converted into a salt by mixing with a pharmaceutically acceptable acid in a solvent such as water, methanol, ethanol, or acetone. Examples of pharmaceutically acceptable acids include inorganic acids such as hydrochloric acid, hydrobromic acid, sulfate, phosphoric acid, and nitric acid, and organic acids such as acetic acid, propionic acid, oxalic acid, succinic acid, lactic acid, malic acid, tartaric acid, citric acid, maleic acid, fumaric acid, methanesulfonic acid, p-toluenesulfonic acid, and ascorbic acid.

[0021] Additionally, the compounds can be administered orally or parenterally (eg, by intravenous, subcutaneous, or intramuscular injection, topically, rectally, transdermally, or intranasally).

[0022] Anti-inflammatory agents for oral administration can be prepared by adding pharmaceutically acceptable and commonly used excipients, binders, lubricants, disintegrants, surfactants, flow enhancers, etc. Examples of excipients that can be used include lactose, fructose, glucose, corn starch, sorbitol, and crystalline cellulose.

[0023] As the binder, methyl cellulose, ethyl cellulose, gum arabic, gelatin, hydroxypropyl cellulose, polyvinylpyrrolidone, etc. can be used. As the lubricant, talc, magnesium stearate, polyethylene glycol, hardened vegetable oil, etc. can be suitably used.

[0024] Disintegrants that can be used include starch, sodium alginate, gelatin, calcium carbonate, calcium citrate, dextrin, magnesium carbonate, synthetic magnesium silicate, etc. Surfactants that can be used include sodium lauryl sulfate, soybean lecithin, sucrose fatty acid ester, polysorbate 80, etc.

[0025] Fluidity promoters that can be used include light anhydrous silicic acid, dried aluminum hydroxide gel, synthetic aluminum silicate, magnesium silicate, etc. Other additives that can be used include syrup, petrolatum, glycerin, ethanol, propylene glycol, citric acid, sodium chloride, sodium nitrite, sodium phosphate, etc.

[0026] In addition, the anti-inflammatory agent of the present invention may be prepared in a dosage form appropriate for the administration route, and may be prepared into various preparations such as oral administration agents such as capsules, tablets, granules, powders, pills, and fine granules, and parenteral administration agents such as injections, rectal administration agents, oily suppositories, aqueous suppositories, and liniments. In addition to the above-mentioned compound, the anti-inflammatory agent of the present invention may contain other pharmacologically active ingredients.

[0027] The anti-inflammatory agent according to the present invention can be used as a therapeutic agent for known conditions that are believed to be improved by anti-inflammatory activity. For example, it can be suitably applied to acne, but is not limited to this, and is expected to suppress inflammation associated with the expression of inflammatory cytokines caused by the generation of NO or reactive oxygen species.

[0028] The compound according to the present invention can also be provided as a processed food composition. The processed food composition according to the present invention may be referred to as an anti-inflammatory processed food composition. Processed food compositions include not only general processed foods including luxury foods and health foods such as candy, gum, jelly, biscuits, cookies, rice crackers, bread, noodles, fish and meat paste products, tea, soft drinks, coffee drinks, milk drinks, whey drinks, lactic acid bacteria drinks, yogurt, ice cream, pudding, etc., but also health functional foods such as foods for specified health uses and foods with nutrient functions specified in the Health Function Foods System of the Ministry of Health, Labor and Welfare, and further include nutritional supplements (supplements), feed, food additives, etc.

[0029] The compounds according to the present invention can also be provided as cosmetics. As cosmetics, at least one of the compounds according to the present invention may be used as is, or ingredients typically used in topical medications may be added in addition to the active ingredients. This does not preclude the overlap with the case of the anti-inflammatory agent described above.

[0030] Suitable other components include polymers, proteins and their hydrolysates, mucopolysaccharides, etc. Examples of polymers include, but are not limited to, carboxyvinyl polymers, xanthan gum, and sodium alginate.

[0031] Examples of proteins and their hydrolysates include collagen, elastin, keratin, casein, their hydrolysates, salts of the hydrolysates, esters of the hydrolysates, and enzyme-treated proteins, with collagen being particularly preferred, as collagen production is inhibited by ultraviolet light.

[0032] Examples of mucopolysaccharides include chondroitin sulfate, hyaluronic acid, dermatan sulfate, heparan sulfate, mucoitin sulfate, heparin and its derivatives, and their salts, among which chondroitin sulfate, hyaluronic acid, and their sodium salts are particularly preferred.Hyaluronic acid is particularly inhibited in synthesis, so it is desirable to use it together with an anti-inflammatory agent.

[0033] Furthermore, moisturizers, water-soluble polymers, oil components, colorants, antioxidants, sequestering agents, preservatives, pH adjusters, cooling agents, fragrances, ultraviolet absorbing / scattering agents, etc. may be added within a range that does not impair the anti-inflammatory effect.

[0034] The anti-inflammatory composition may also be provided as an anti-skin aging pharmaceutical composition or an anti-skin aging processed food composition.

[0035] The inflammatory response in the body is a defense mechanism for the body's defense against external invasion by bacteria, viruses, or chemicals. This defense mechanism is an important mechanism for the body's defense against external invasion by various cells, such as mast cells, neutrophils, macrophages, and lymphocytes, and for the effective removal of foreign substances and tissue repair. However, excessive inflammatory responses can cause chronic inflammatory conditions known as allergies and autoimmune diseases, resulting in harmful reactions.

[0036] Acne is an inflammatory disease that occurs in the pilosebaceous gland. It is believed that the development of acne is related to the anaerobic, gram-positive bacterium, Cutibacterium acnes (hereinafter referred to as "C. acnes"). Although C. acnes is a normal inhabitant of human skin, it overgrows and causes inflammation due to factors such as clogged pores caused by sebum or a decrease in the skin's barrier function due to disrupted cell turnover. Toll-like receptor (TLR) 1 / 2 heteroreceptors and TLR 2 / 6 heteroreceptors present on the cell membrane surface of macrophages and keratinocytes are activated by recognizing lipoteichoic acid and peptidoglycan, which are major components of the cell wall of C. acnes.

[0037] This induces the expression of inducible nitric oxide synthase (hereinafter referred to as "iNOS") and cyclooxygenase-2 (hereinafter referred to as "COX-2"), resulting in the production of nitric oxide (hereinafter referred to as "NO") and prostaglandin E2 (hereinafter referred to as "PGE 2 ") and induces an inflammatory response in the body. 2 Inhibiting the activation of signal transduction factors involved in production can be linked to anti-inflammatory agents that are effective in suppressing inflammation caused by acne bacteria.

[0038] The CH and CT used in this study were provided by Professor Mamoru Koketsu et al. of the Department of Functional Materials Engineering, Faculty of Engineering, Gifu University, National University Corporation, Tokai National Higher Education and Research System. However, as disclosed in Patent Document 1, they can also be extracted from young watermelon fruits by the following method.

[0039] <Method for extracting compounds> 2 kg (wet weight) of young fruits of the CS variety of watermelon (15 days after fruiting) was crushed, and 5 L of ethanol was added to the crushed material, followed by stirring at room temperature to prepare an ethanol extract.

[0040] The ethanol eluate was partitioned sequentially with hexane, ethyl acetate, and butanol to prepare various elution fractions and a distilled water solution. The ethyl acetate layer was purified on a column to obtain multiple fractions. CH and CT were isolated from two of these fractions.

[0041] <Identification of Substances> The NMR spectra of each compound are as follows.

[0042] 2-Caffeoyl-3-hydroxy-3-methylbutyric 4'-β-D-glucopyranosyloxy-3'-hydroxybenzyl ester: 1 H NMR (400MHz, Acetone-d 6): δ7.63 (1H, d, J=15.6Hz, H-γ''), 7.16 (1H, d, J=1.8Hz, H-2''), 7.12 (1H, d, J=8.2Hz, H-5'), 7.03 (1H, dd, J=8.2 and 1.8Hz, H-6''), 6.91 (1H, d, J=2.3Hz, H-2'), 6.85 (1H, d, J=7.8Hz, H-5''), 6.80 (1H, d, J=8.2 and 2.3Hz, H-6'), 6.35 (1H, d, J = 16.0Hz, H-β''), 5.07 (2H, s, H-α'), 4.85 (1H, s, H-2), 4.74 (1H, d, J = 7.3Hz, H- 1'''), 3.92-3.84 (1H, m, H-6α'''), 3.73-3.68 (1H, m, H-6β'''), 3.52-3.43 (4H, m, H-2''', H-3''', H-4''', and H-5'''), 1.31 (3H, s, H-4), 1.30 (3H, s, H-5); 13 C NMR (100MHz, Acetone-d 6 ): δ168.5, 166.3, 148.3, 147.9, 146.1, 145.6, 145.3, 131.9, 126.6, 122.0, 119.6, 118.4, 116.0, 115 .6,114.5,113.8,103.4,79.3,77.2,76.6,73.9,70.5,70.4,66.1,61.7,25.8 (2C): HRESITOFMS: m / z 603.1678 [M+Na] + (calcd. for C 27 H 32 O 14 Na, 603.1690). The above is the "CT" in equation (1).

[0043] Also, 2-caffeoyl-3-hydroxy-3-methylbutyric 4'-β-D-glucopyranosyloxybenzyl ester (2-Caffeoyl-3-hydroxy-3-methylbutyric 4'-β-D-glucopyranosyloxybenzyl ester): 1 H NMR (400MHz, Acetone-d 6): δ7.63 (1H, d, J = 16.0Hz, H-γ''), 7.31 (2H, d, J = 8.7Hz, H-2' and H-6'), 7.16 (1H, d, J = 1.8Hz, H-2''), 7.05-7.00 (3H, m, H-3', H-5', and H-6''), 6.85 (1H, d, J = 8.3Hz, H-5''), 6.35 (1H, d, J = 16.0Hz, H-β''), 5.11 (2H, s, H-α'), 4.94 (1H, d, J = 7.8Hz, H-1'') , 4.84 (1H, s, H-2), 3.89-3.84 (1H, m, H-6α'''), 3.72-3.65 (1H, m, H-6β'''), 3.53-3.42 (4H, m, H-2''', H-3''', H-4''', and H-5'''), 1.30 (3H, s, H-4), 1.28 (3H, s, H-5); 13 C NMR (100MHz, Acetone-d 6 ): δ168.5, 166.3, 157.9, 148.3, 146.2, 145.6, 129.8 (2C), 129.6, 126.6, 122.0, 116.4 (2C), 115.6 , 114.5, 113.8, 100.9, 79.3, 77.1, 76.9, 73.8, 70.5, 70.4, 66.0, 61.8, 25.7 (2C); HRESITOFMS: m / z 587.1716 [M+Na] + (calcd. for C 27 H 32 O 13 Na, 587.1741). The above is "CH" in formula (2).

[0044] <Antibacterial activity of CH and CT against acne bacteria> First, the antibacterial activity of CH and CT against acne bacteria (C. acnes) was examined. The acne bacteria strain was obtained from the National Institute of Technology and Evaluation (Kisarazu, Chiba Prefecture). The acne bacteria was inoculated into GAM liquid medium (Nissui Pharmaceutical Co., Ltd., Tokyo) sterilized at 121°C, and the medium was inoculated with Anaeropack (registered trademark) CO. 2 (Mitsubishi Gas Chemical Co., Inc., Tokyo) was used and cultured at 37°C under anaerobic conditions.

[0045] P. acnes was evenly spread on GAM agar medium in a sterile dish using a Conrad stick (5 × 10 5CFU / dish), and filter paper impregnated with CH and CT (6, 30, and 60 μg / mL) or different concentrations of benzalkonium chloride (referred to as "BZC") (1.25%, 2.5%, 5%, and 10%) as a positive control was placed on top. After 24 hours of incubation at 37°C, the diameter of the growth inhibition zone around the filter paper was measured.

[0046] The results are shown in Figure 2. Referring to Figure 2, the horizontal axis represents the type and concentration of the drug impregnated in the filter paper, and the vertical axis represents the diameter (mm) of the growth inhibition zone. The size of the growth inhibition zone is shown as the mean ± standard error. Note that n = 3.

[0047] In the case of filter paper containing benzalkonium chloride, the size of the growth inhibition zone increased with increasing concentration. However, in the case of filter paper containing CH and CT, no growth inhibition zone was observed even at higher concentrations. Therefore, it was thought that CH and CT themselves did not have an antibacterial effect against P. acnes.

[0048] <NO Production Inhibitory Effect in LPS / IFN-γ Stimulated Cells> Next, the NO production ability of macrophages pretreated with CT or CH when stimulated with LPS or IFN-γ was examined.

[0049] <<Cell Culture>> Mouse macrophage RAW264.7 cells (hereinafter simply referred to as "RAW264.7 cells") were obtained from RIKEN (Tsukuba, Ibaraki Prefecture). RAW264.7 cells were cultured in Dulbecco's modified Eagle's medium (DMEM, Sigma-Aldrich, MO, USA) containing 10% fetal bovine serum, 50 U / mL penicillin, and 50 μg / mL streptomycin at 37°C under 95% air and 5% CO. 2 It was cultivated under the environment.

[0050] RAW264.7 cells (2 x 10 5500 μL of RAW264.7 cells / mL) was seeded into a 24-well multiplate and cultured for 24 hours. Then, CH and CT were added to final concentrations of 25, 50, 100, and 200 μM, and pretreatment was performed for 2 hours. After pretreatment, LPS (Sigma-Aldrich) and IFN-γ (Merck Millipore, MA, USA) were simultaneously added to a final concentration of 200 ng / mL and 25 ng / mL, respectively, and stimulation was performed for 24 hours. After stimulation, nitrite (NO), a decomposition product of NO produced by RAW264.7 cells, was detected. 2 - ) was developed with Griess reagent (Promega, WI, USA), and the absorbance at 540 nm was measured using a Varioskan LUX multimode microplate reader (Thermo Fisher Scientific, MA, USA) to indirectly measure the amount of NO production.

[0051] The results are shown in Figure 3. Referring to Figure 3, the horizontal axis indicates the sample and concentration, and the vertical axis indicates the NO concentration (ratio to untreated cells not stimulated with LPS / IFN-γ). The NO production amount is shown as the mean ± standard error (n = 8). The significance of the difference between the two groups was tested using the Student's t test. Compared to untreated cells (LPS / IFN-γ: -), #p<0.001, and compared to LPS / IFN-γ-treated cells (LPS / IFN-γ: +), ***p<0.001. Other substances with anti-inflammatory effects were also measured: quercetin (denoted as "Que") and the steroidal anti-inflammatory agent dexamethasone (denoted as "Dexa").

[0052] Stimulation with LPS / IFN-γ increased NO production in RAW264.7 cells by approximately 8.5-fold compared to untreated cells. However, this NO production was reduced by approximately 30% with 200 μM CH treatment and by approximately 27% with 200 μM CT treatment. This was approximately the same level as the inhibitory effect of dexamethasone on NO production.

[0053] <Inhibitory Effect on NO Production in Cells Stimulated with Heat-Killed Propionibacterium acnes Cells> Next, the amount of NO produced in cells stimulated with heat-killed Propionibacterium acnes cells was examined.

[0054] <<Preparation of heat-killed acne bacteria>> P. acnes was inoculated into GAM liquid medium (Nissui Pharmaceutical Co., Ltd., Tokyo) sterilized at 121°C and cultured with shaking at 37°C for 72 hours. The culture solution was sterilized at 121°C using an autoclave and then subjected to a high-speed refrigerated centrifuge (CR22GIII, Koki Holdings Co., Ltd., Tokyo) at 10,000 x g and 4°C for 30 minutes. The heat-killed bacteria were freeze-dried using a freeze dryer (FDS-1000, Tokyo Rikakikai Co., Ltd., Tokyo) and stored at -30°C.

[0055] RAW264.7 cells (2 x 10 5 500 μL of RAW264.7 cells (100 μg / mL) was seeded into a 24-well multiplate and cultured for 24 hours. Then, CH and CT were added to final concentrations of 25, 50, 100, and 200 μM, and pretreatment was performed for 2 hours. After pretreatment, heat-killed Propionibacterium acnes cells were added to a final concentration of 200 μg / mL, and stimulation was performed for 24 hours. After stimulation, the NO concentration produced by RAW264.7 cells was measured by color development using Griess reagent (Promega).

[0056] The results are shown in Figure 4. Referring to Figure 4, the horizontal axis represents the type and concentration of the sample, and the vertical axis represents the NO concentration (ratio to untreated cells not stimulated with heat-killed P. acnes cells). Stimulation with heat-killed P. acnes cells increased the amount of NO produced by RAW264.7 cells by approximately 10-fold compared to untreated cells. However, treatment with 200 μM CH reduced this NO production by approximately 73%. Furthermore, treatment with CT reduced NO production in a concentration-dependent manner, with a reduction of approximately 87% after 200 μM treatment.

[0057] <Amount of NO-producing signal protein in cells stimulated with heat-killed P. acnes cells> In macrophages, when lipoteichoic acid and peptidoglycan, which are major components of the cell wall of P. acnes, are recognized by heteroreceptors of TLR1 / 2 and TLR2 / 6, the inflammatory signal transduction system in the cytoplasm is activated, inducing the expression of iNOS and producing NO. In this study, we confirmed the suppression of NO production in RAW264.7 cells stimulated with heat-killed P. acnes cells by CH and CT treatment, and therefore, we confirmed that the suppression of NO production was due to the activation of inducible nitric oxide synthase (iNOS), which is involved in NO production, and prostaglandin E, which has the effect of promoting the production of inflammatory cytokines and causing pain. 2 (PGE 2 We investigated the protein level of COX-2, which is involved in the production of COX-2 and is induced by inflammatory stimuli.

[0058] <<Collection of cell lysate samples and adjustment of protein concentration>> RAW264.7 cells (2 x 10 5 Three mL of the medium (300 μg / mL) was seeded into a 6-well multiplate and cultured for 24 hours. Then, CH and CT were added to a final concentration of 200 μM, and pretreatment was performed for 2 hours. After pretreatment, heat-killed Propionibacterium acnes cells (final concentration: 200 μg / mL) were added and stimulation was performed for 24 hours. After stimulation, the 6-well plate was washed with PBS (0.5 mL x 3 times), and the cells were lysed in RIPA buffer (25 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) containing 2% protease inhibitor, and the cells were collected using a cell scraper. The protein concentration in the sample solution was measured using a Bio-Rad DC Protein Assay kit (Bio-Rad) with bovine serum albumin (Bio-Rad, CA, USA) as a standard substance. A sample buffer containing 10% mercaptoethanol was added to the sample solution with the adjusted protein concentration, and the mixture was left at 98°C for 5 minutes to prepare a sample for Western blot analysis.

[0059] <<SDS-PAGE>> A 10 or 12% gel suitable for detecting the target protein was placed in an electrophoresis tank (Mini PROTEAN Tetra Cell, Bio-Rad), and electrophoresis buffer (10x Tris / Glycine / SDS Buffer, Bio-Rad: 10%, ultrapure water: 90%) was added to the electrophoresis tank. Protein molecular weight markers and samples were applied to each lane of the gel, and electrophoresis was performed at 125 V for 1.5 to 2 hours to separate the proteins in the samples.

[0060] <<Western Blotting>> After SDS-PAGE was completed, the gel was removed using a spatula, and only the necessary gel portion was immersed in blotting buffer (10x Tris / Glycine Buffer, Bio-Rad: 10%, methanol: 20%, ultrapure water: 70%). A polyvinylidene difluoride (hereinafter referred to as PVDF, GE Healthcare UK Ltd., Buckinghamshire, UK) membrane was immersed in methanol for 1 minute for hydrophilic treatment, and then immersed in blotting buffer. The PVDF membrane was placed on top of the gel, sandwiched between filter paper soaked in blotting buffer, and set in a blotting apparatus (Mini Trans Blot Cell, Bio-Rad). Thereafter, the protein was transferred to a PVD membrane at 60 V for 90 minutes while being cooled with ice water.

[0061] After blotting, the PVDF membrane was immersed in a 5% skim milk solution prepared by dissolving skim milk (Difco Laboratories Inc., MI, USA) in 1×T-TBS for 1 hour and shaken to perform blocking. After blocking, the PVDF membrane was washed with 1x T-TBS by shaking (10 minutes x 3 times), and then immersed in various primary antibodies (iNOS: #2982, iNOS: #13120, NOS (pan): #2977, COX-2: #4842, Heme Oxygenase-1: #5141, β-Actin: #4967, Cell Signaling Technology, MA, USA) diluted 1:1000 with Can Get Signal Solution 1 (Toyobo Co., Ltd., Osaka Prefecture) and shaken overnight at 4°C.

[0062] The PVDF membrane was washed with 1x T-TBS by shaking (5 minutes x 3 times), and then incubated with a secondary antibody (ECL) diluted 10,000 times with 5% skim milk solution. TM Anti-Rabbit IgG, Horseradish Peroxidase or ECL TM  The PVDF membrane was immersed in Anti-Mouse IgG, Horseradish Peroxidase (GE Healthcare UK Ltd.) for 1 hour with shaking. The PVDF membrane was then washed with shaking in 1x T-TBS (10 minutes x 3 times), treated with ECL (GE Healthcare UK Ltd.), and detected with a chemiluminescence detection device (iBrightTMFL1500 Instrument, Thermo Fisher Scientific).

[0063] The results are shown in Figure 5. Figure 5(a) shows the results of Western blotting. The protein expression of iNOS and COX-2 by Western blotting is shown (-: untreated, +: stimulated with heat-killed P. acnes cells, CH, CT: treated with 200 μM, sample protein amount: 15 μg protein / lane).

[0064] Figures 5(b) and 5(c) show the band intensities of the Western blotting in Figure 5(a). Figure 5(b) shows the band intensities of iNOS, and Figure 5(c) shows the band intensities of COX-2. In both Figures 5(b) and 5(c), the horizontal axis represents sample and concentration, and the vertical axis represents the comparative band intensity (comparison of C. acnes, CT, and CH to untreated samples). In Figure 5, abc indicates significant differences based on statistical processing; the same symbol indicates no significant difference, and different symbols indicate significant differences.

[0065] 5(b) and 5(c), RAW264.7 cells were stimulated with P. acnes to express iNOS and COX-2. Furthermore, pretreatment with 200 μM of CH and CT suppressed the expression of iNOS and COX-2.

[0066] <Amount of mRNA for NO-producing signal protein in cells stimulated with heat-killed P. acnes cells> The mRNA expression of iNOS, COX-2, and inflammatory cytokines was evaluated in RAW264.7 cells stimulated with heat-killed P. acnes cells.

[0067] <<Total RNA extraction and preparation>> RAW264.7 cells (2 x 10 5 Three mL of the culture medium (3 mL / mL) was seeded into a 6-well multiplate and cultured for 24 hours. Then, CH and CT were added to a final concentration of 200 μM, and pretreatment was performed for 2 hours. After pretreatment, heat-killed Propionibacterium acnes cells (final concentration: 200 μg / mL) were added, and stimulation was performed for 12 hours.

[0068] After stimulation, the 6-well plate was washed with PBS (0.5 mL x 3 times), TRIzol reagent (Thermo Fisher Scientific) was added in 0.5 mL portions, and the cells were collected using a cell scraper. 200 μL of chloroform was then added and the plate was centrifuged (12,700 × g, 15 minutes, 4°C). The supernatant was transferred to another tube, 500 μL of 2-propanol was added, and the plate was left at room temperature for 10 minutes before being centrifuged (12,700 × g, 10 minutes, 4°C).

[0069] After centrifugation, 500 μL of 75% ethanol was added to the precipitate, followed by centrifugation (7,800 × g, 5 minutes, 4°C). The precipitate was dried at room temperature for 30 minutes, and 180 μL of DEPC water was added to dissolve the precipitate. After dissolution, 20 μL of 10× buffer and 2 μL of DNase were added, and the mixture was left at 37°C for 1 hour.

[0070] After leaving it for 1 hour, 40 μL of sodium acetate (Wako Pure Chemical Industries, Ltd., Osaka) and 150 μL of phenol-chloroform were added, followed by centrifugation (21,500 × g, 5 minutes, 4°C). After centrifugation, 800 μL of ethanol was added to the supernatant, followed by centrifugation (21,500 × g, 30 minutes, 4°C).

[0071] After centrifugation, the precipitate was washed with 200 μL of 75% ethanol and centrifuged (21,500 × g, 15 minutes, 4 ° C). The precipitate was then dried at room temperature for 1 hour, and 10 μL of DNase-RNase-free water was added to prepare a total RNA solution sample. The RNA concentration of the total RNA solution sample was measured using a spectrophotometer (Nano Drop™ Lite, Thermo Fisher Scientific), and the RNA concentration of the sample was adjusted with DNase-RNase-free water to 125 ng / μL, an RNA concentration suitable for reverse transcription reactions.

[0072] <<Reverse transcription reaction from RNA to cDNA>> An RNA sample and DNase-RNase-free water were prepared and added to an RT master mix prepared by mixing 10 μL of 2×RT Buffer and 1 μL of 20×RT Enzyme Kit, which are components of the High Capacity RNA-to-cDNA Kit (Thermo Fisher Scientific), so that the total volume was 20 μL and the RNA concentration was 6.25 ng / μL. Next, using a Veriti 96-well Thermal Cycler (Thermo Fisher Scientific), reverse transcription reaction from RNA to cDNA was carried out at 37°C for 60 minutes (reverse transcription reaction), 95°C for 5 minutes (thermal inactivation of reverse transcriptase), and 4°C (cooling).

[0073] <<Real-time PCR>> A real-time PCR reaction solution was prepared by adding 10 μL of Power SYBR Green PCR master mix (Thermo Fisher Scientific), 6.4 μL of DNase-RNase-free water, 2 μL of cDNA sample solution, and 0.8 μL of 10 μM each primer (Takara Bio Inc., Shiga Prefecture, Japan, Table 1) diluted 5-fold with DNase-RNase-free water. In Table 1, A represents adenine, T represents thymine, C represents cytosine, and G represents guanine.

[0074] The real-time PCR reaction solution was placed in a Fast Optical 48-well Reaction Plate (Thermo Fisher Scientific) at 20 μL / well, and the plate was covered with a 48-well Optical Adhesive Film (Thermo Fisher Scientific).

[0075] Then, PCR was performed using a Step One Real-Time PCR System (Thermo Fisher Scientific) to measure the amount of mRNA. The PCR conditions were as follows: Holding Stage: 95°C for 10 minutes, Cycle Stage: 95°C for 15 seconds, 60°C for 1 minute (45 cycles), and Melt Curve Stage: 95°C for 15 seconds, 60°C for 1 minute.

[0076]

[0077] The results are shown in Figure 6. Figure 6(a) shows the results of iNOS mRNA levels measured by qRT-PCR, and Figure 6(b) shows the results of COX-2 mRNA levels measured by qRT-PCR. Data are shown as mean ± standard error (n = 4). The significance of the difference between the two groups was tested using the Student's t test. #p<0.001 compared to untreated cells (C. acnes: -), *p<0.05, **p<0.01 compared to cells treated with heat-killed P. acnes bacteria (C. acnes: +).

[0078] In both graphs, the horizontal axis represents the sample and concentration, and the vertical axis represents the ratio of each mRNA amount to GAPDH (glyceraldehyde-3-phosphate dehydrogenase) mRNA. GAPDH is a housekeeping gene found in all cells, and by calculating the ratio, the amounts of each mRNA can be compared.

[0079] 6, RAW264.7 cells were stimulated with P. acnes to express iNOS and COX-2 mRNA. Furthermore, pretreatment with 200 μM of CH and CT suppressed the expression of iNOS and COX-2 mRNA.

[0080] <Amount of mRNA of inflammatory cytokines (TNF-α, IL-6) in RAW264.7 cells stimulated with heat-killed Propionibacterium acnes cells> Next, the mRNA expression levels of inflammatory cytokines with pro-inflammatory effects were examined in RAW264.7 cells stimulated with heat-killed Propionibacterium acnes cells treated with CH and CT. The experimental method was the same as that shown in <Amount of mRNA of NO production signal protein in cells stimulated with heat-killed Propionibacterium acnes cells>. The primers for TNF-α and IL-6 are listed in Table 1.

[0081] The results are shown in Figure 7. Figure 7(a) shows the results for the mRNA expression level of TNF-α, and Figure 7(b) shows the results for the mRNA expression level of IL-6. Data are shown as mean ± standard error (n = 6). A significant difference between the two groups was tested using the Student's t test. Compared to untreated cells (C. acnes: -), #p<0.001, and compared to cells treated with heat-killed Propionibacterium acnes bacteria (C. acnes: +), *p<0.05 and **p<0.01. In both graphs, the horizontal axis shows the sample and concentration, and the vertical axis shows the ratio of each mRNA amount to the GAPDH mRNA amount.

[0082] 7, RAW264.7 cells were stimulated with heat-killed Propionibacterium acnes cells to express TNF-α and IL-6 mRNA. A statistically significant change in TNF-α mRNA expression was observed with 200 μM CT treatment, but no change in mRNA expression was observed with CH treatment. On the other hand, IL-6 mRNA expression was reduced by approximately 56% with CH treatment and approximately 44% with CT treatment compared to cells stimulated only with heat-killed Propionibacterium acnes cells.

[0083] <Induction of protein expression of heme degrading enzyme HO-1 by CH and CT treatment> Quercetin, a flavonoid abundant in vegetables and fruits such as onions and apples, has been reported to activate the NF-E2-related factor 2 (Nrf2)-antioxidant responsive element (ARE) signaling and induce the expression of heme oxygenase-1 (hereinafter referred to as HO-1), thereby suppressing LPS-induced inflammation in RAW264.7 cells. HO-1 is an enzyme that catalyzes the degradation of heme, and this reaction degrades heme by carbon monoxide (CO), biliverdin, and Fe. 2+ These metabolites act as cytoprotective agents through their anti-inflammatory and antioxidant properties. Therefore, we investigated the changes in the expression levels of HO-1 mRNA and protein after 2 hours of pretreatment with CH and CT.

[0084] The experimental method for protein amount was in accordance with <Amount of NO-producing signal protein in cells stimulated with heat-killed P. acnes cells> (results shown in Figure 5), and for mRNA amount was in accordance with <Amount of mRNA of NO-producing signal protein in cells stimulated with heat-killed P. acnes cells> (results shown in Figure 6). Primers for detecting HO-1 were as shown in Table 1.

[0085] The results are shown in Figure 8. Figure 8(a) shows the results of measuring HO-1 mRNA expression by qRT-PCR. The horizontal axis represents the pretreatment concentrations of CH and CT, and the vertical axis represents the relative mRNA amount (relative to the GAPDH mRNA amount). The data are shown as mean ± standard error (n = 6). Comparisons between multiple groups were performed using the Tukey-Kramer method (p < 0.05). In Figure 8, ab indicates significant differences based on statistical processing; the same symbol indicates no significant difference, and different symbols indicate significant differences.

[0086] The expression level of HO-1 mRNA increased by about 1.6 times with CH treatment and by about 1.4 times with CT treatment compared to untreated cells.

[0087] Next, Figure 8(b) shows the results of Western blotting of HO-1. HO-1 protein expression is shown as (-: untreated, CH and CT: treated with 200 μM, sample protein amount: 18 μg protein / lane). The pretreatment concentrations of CH and CT were 200 μM.

[0088] Figure 8(c) is a graph showing the relative band intensity of the bands in Figure 8(b). Referring to Figure 8(c), the horizontal axis represents CH, CT, and untreated samples, and the vertical axis represents the relative amount of HO-1 protein (β-actin as a reference). β-actin is a housekeeping protein present in cells. Figure 8(c) shows that HO-1 protein expression in RAW264.7 cells treated with CH and CT showed no change compared to untreated cells. In other words, although mRNA for HO-1 production was expressed, it was not translated into actual protein.

[0089] <Induction of mRNA expression in M1 / M2 macrophages by CH and CT treatment> Macrophages are cells that become activated during bacterial infection or cancer cell development, producing inflammatory substances such as nitric oxide (NO) and functioning as a defense mechanism against the body. There are two activation pathways for macrophages: the classical activation (M1) pathway and the alternative activation (M2) pathway. M1 macrophages have pro-inflammatory properties, while M2 macrophages have anti-inflammatory properties. Furthermore, it has been shown that these activation states can be alternated by specific signals.

[0090] Markers that indicate M1 macrophage activation include cluster of differentiation 80 (hereinafter referred to as CD80) and cluster of differentiation 86 (hereinafter referred to as CD86), which are expressed on the cell membrane of M1 macrophages, and iNOS, which is expressed in M1 macrophage cells. Markers that indicate M2 macrophage activation include cluster of differentiation 206 (hereinafter referred to as CD206), which is expressed on the cell membrane of M2 macrophages, and arginase-1 (hereinafter referred to as Arg-1), which is expressed in M2 macrophage cells.

[0091] Therefore, we investigated the mRNA expression levels of CD80, CD86, CD206, and Arg-1, which are indicator markers of M1 / M2 macrophage activation, in RAW264.7 cells stimulated with heat-killed P. acnes cells treated with CH or CT.

[0092] The experimental method was in accordance with the method described in <Amount of mRNA of NO production signal protein in cells stimulated with heat-killed P. acnes cells> (the results are shown in FIG. 6). Primers for CD80, CD86, CD206, and Arg-1 were those listed in Table 1.

[0093] Figure 9 shows the results of measuring the mRNA expression levels of CD80 and CD86. Figure 9(a) shows the results of measuring CD80, and Figure 9(b) shows the results of measuring CD86. Data are shown as mean ± standard error (n = 6). Comparisons between multiple groups were performed using the Tukey-Kramer method (p < 0.05). In both graphs, the horizontal axis indicates the sample and concentration, and the vertical axis indicates the ratio of each mRNA amount to the GAPDH mRNA amount. In Figure 9, abc indicates significant differences based on statistical processing; the same symbols indicate no significant difference, and different symbols indicate significant differences.

[0094] The mRNA expression of both CD80 and CD86 was decreased by CH or CT treatment compared to cells stimulated with heat-killed P. acnes cells (RAW264.7).

[0095] 9(a), CD80 mRNA expression was reduced by approximately 42% by CH treatment and by approximately 50% by CT treatment compared to untreated cells. 9(b), CD86 mRNA expression was reduced by approximately 44% by CH treatment and by approximately 67% by CT treatment compared to untreated cells.

[0096] The expression level of iNOS mRNA, which is an indicator marker of M1 macrophage activation like CD80 and CD86, was significantly increased in RAW264.7 cells stimulated with heat-killed P. acnes cells (see Figure 6(a)). However, as mentioned above, this level was also significantly reduced by CH and CT treatment (see Figure 6(a)), suggesting that CH and CT treatment reduced M1 macrophage activation.

[0097] However, CD206 and Arg-1, which are indicator markers of M2 macrophage activation, were not detected, meaning that there was no confirmation that macrophages were shifted to M2 macrophages by CH and CT treatment.

[0098] <Effect on NF-κB transcription activity in RAW264.7 cells stimulated with heat-killed Propionibacterium acnes cells> To investigate the mechanism by which CH and CT treatments suppress inflammation caused by stimulation with heat-killed Propionibacterium acnes cells, a luciferase reporter sensor vector was used.

[0099] <<NF-κB Reporter Assay>> <<Transfection of NF-κB Reporter Vector into RAW264.7 Cells (Gene Transfection)>> Mouse macrophage RAW264.7 cells adjusted to 4.0 x 106 cells / mL were resuspended in 240 μL of Resuspension Buffer R (Neon Transfection System, Invitrogen, MA, USA), an electrotransfection reagent. 12 μL (0.5 μg) of Luc2P / NF-κB-RE / Hygro and 24 μL of pRL-SV40 vector (20 ng / μL) were then added.

[0100] Next, 3 mL of electrolytic buffer was added to the Neon (registered trademark) tube, and the tube was set in the Neon (registered trademark) pipette station. 100 μL of the prepared RAW264.7 cells were then collected using a Neon (registered trademark) pipette with a Neon (registered trademark) tip inserted, and set in the Neon (registered trademark) tube for gene transfer (1720 V, 10 ms, 2 plus).

[0101] The transfected cells were seeded in 100 μL aliquots onto 12-well multi-plates containing 900 μL of DMEM medium and cultured overnight. After adhesion, the cells were incubated with heat-killed Propionibacterium acnes (final concentration: 200 μg / mL) to induce an inflammatory response for 24 hours. After 6 hours of stimulation, the cells were washed twice with PBS, lysed by adding 100 μL of passive lysis buffer, and collected into 1.5 mL tubes using a cell scraper.

[0102] <<Reporter Assay>> 100 μL of Luciferase Substrate was added to each 1.5 mL tube, and 20 μL of the collected cell lysate was added thereto. The luminescence intensity of firefly luciferase incorporated into the NF-κB vector was measured using a luminometer (Promega Corporation, GloMax (registered trademark) 20 / 20 Luminometer, Wisconsin, USA). After measurement, 100 μL of Stop&Glo (registered trademark) Buffer was added, and the luminescence intensity of Renilla luciferase incorporated into pRLSV40 was measured. As a positive control, the luminescence intensity of RAW cells treated with 25 μM of the NF-κB inhibitor APDC (Ammonium Pyrrolidinedithiocarbamate) was measured.

[0103] Data are shown as mean ± standard error. Significant differences between two groups were tested using Student's t test, and comparisons between multiple groups were performed using the Tukey-Kramer method (*p<0.05, **p<0.01, #***p<0.001).

[0104] The results are shown in Figure 10. Referring to Figure 10, the horizontal axis represents sample type and concentration, and the vertical axis represents the relative transcription level of NF-κB based on the Renilla luciferase luminescence intensity. Data are shown as mean ± standard error (n = 6). Comparisons between multiple groups were performed using the Tukey-Kramer method (p < 0.05). In Figure 10, abc indicates significant differences based on statistical processing; the same symbols indicate no significant difference, and different symbols indicate significant differences.

[0105] 10, both CH and CT treatments reduced the transcriptional activity of NF-κB by approximately 50%. Although this activity was weaker than that of the positive control APDC 25 μM treatment, this suggests that CH and CT treatments suppress nitric oxide production by attenuating Toll-like receptor 1 and 2 or TLR2 / 6 signaling activated by stimulation with heat-killed P. acnes cells.

[0106] From the above, it was shown that CH and CT are compounds that have anti-inflammatory effects, and more specifically, they are useful as cosmetic ingredients that suppress inflammation caused by acne bacteria.

[0107] The watermelon-derived compounds CT and CH according to the present invention are compounds having anti-inflammatory activity, and are expected to be effective in suppressing inflammation in the body in various aspects.

Claims

1. 1. A therapeutic agent for acne, comprising as an active ingredient a compound represented by formula (1) or (2). 【Chemistry 101】 【Chemistry 102】

2. The acne treatment drug according to claim 1, which has no antibacterial effect against Propionibacterium acnes.

3. A cosmetic product for suppressing acne, comprising at least one of a compound represented by formula (1) or (2). 【Chemistry 103】 【Chemistry 104】

4. The cosmetic product according to claim 3, which does not exhibit an antibacterial effect against Propionibacterium acnes.

5. A processed food for suppressing acne, comprising at least one of a compound represented by formula (1) or (2). 【Chemistry 105】 【Chemistry 106】